Skip to main content

Health Services: Technology

Question for Department of Health and Social Care

UIN 32038, tabled on 19 March 2020

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the implications for his policies on (a) improving access to innovative medicines and (b) fostering the life sciences sector of the National Institute for Health and Care Excellence health technology evaluation review.

Answered on

29 May 2020

The National Institute for Health and Care Excellence (NICE) is reviewing its methods for the development of technology appraisal and highly specialised technology recommendations in line with the commitment in the 2019 voluntary scheme for branded medicines pricing and access. The scheme also states the Government’s expectations for the review as follows: ‘“The Department expects that any future changes to NICE methods and processes would respond to the new types of innovation coming to the market, be consistent with improving the health gain achieved by spending on new innovative medicines, and support faster adoption of the most clinically and cost effective medicines.”’

Answered by

Department of Health and Social Care